跳至主要内容
临床试验/PACTR202405874828622
PACTR202405874828622尚未招募Unknown

Efficacy of Combined Anodal tDCS over M1 and F3 Regions in Diabetic Neuropathic Pain: Double-blind Randomized Controlled Study.

Ain Shams University Faculty of Medicine0 个研究点目标入组 20 人开始时间: 2024年5月12日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 Year(s) 至 64 Year(s)(—)
性别
All

入选标准

  • Type-2 diabetes and neuropathic pain, at least 5 years of diabetes history
  • Aged 45 to 65 years,
  • Ability and willingness to participate in intervention sessions.

排除标准

  • Use of strong painkillers
  • Not suffering from any medical conditions (such as a herniated disc, or injuries from a serious accident that took place within the previous three months) that induce neuropathic and chronic pain
  • History of head or neck surgery.
  • Use of a cardiac pacemaker or defibrillator
  • Subjects with diabetic foot ulcers and amputation were excluded from the study. Diabetic subjects with stroke.
  • Absence in more than two sessions or more than four days between sessions

研究者

相似试验

Efficacy of Combined Anodal tDCS over M1 and F3... | 临床试验